Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Welcoming 2020, we have obtained certifications again and again!
Published Time：
2019-12-20
Double Eleven and Christmas are approaching
Amidst the excitement of welcoming 2020
Recently, Lizhu Reagents has received more good news:
HBV+HCV+HIV(1+2 type) nucleic acid detection
The reagent kit (PCR-fluorescence method) has obtained a drug registration certificate
“This is the best New Year's gift we've received”
From now on, blood safety has a new “protective umbrella”!
On December 17, the National Medical Products Administration issued a drug registration certificate for the "HBV+HCV+HIV (1+2 type) nucleic acid detection kit (PCR-fluorescence method)" independently developed by Lizhu Reagents.
Product Advantages:
★ Single test mode, minimizing the risk of virus transmission through blood
★ Single-tube multiplex technology, directly obtaining HBV, HCV, HIV-1 and HIV-2 positive and negative results
★ No need for mixing, splitting and identification, reducing workload and improving efficiency
★ HBV, HIV-1 use dual-segment amplification to reduce the risk of false negatives caused by mutations
★ Strict multiple anti-pollution technology
★ 2-8℃ transportation and storage, avoiding repeated freezing and thawing, higher reagent stability
As one of the earliest professional service providers in the field of blood safety testing in China, Lizhu Reagents currently has a range of products including blood screening enzyme immunoassays, blood screening colloidal gold series, blood screening standard substance series, and blood screening four-item confirmation series. The approval of this three-item combined nucleic acid detection reagent for blood screening enriches and improves our blood screening product system, providing comprehensive blood screening solutions for major blood banks and hospitals. In addition, the X-ray blood irradiator independently developed by Lizhu Reagents has been approved for listing, providing protection for blood safety.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.